Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.
from Health https://ift.tt/2Ugl3n5
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment